Director, CHIEF EXECUTIVE OFFICER · GeneDx Holdings Corp. · Class A Common Stock
Side
M
Value
—
Shares
6,547
Price
—
Executed
Dec 9, 2025
Disclosed
Dec 11, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 9 executedDec 11, 2025 disclosed
WGS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 190.5% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Stueland Katherine filed this Form 4 reporting a option exercise of WGS on Dec 9, 2025. It became public on Dec 11, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CHIEF EXECUTIVE OFFICER
Stueland Katherinecik:0001689575
Issuer
GeneDx Holdings Corp.cik:0001818331
Revision history · 0
No field has changed since this record was first ingested.
